Skip to main content
. 2019 Jan 11;33(7):1747–1758. doi: 10.1038/s41375-018-0351-2

Fig. 3.

Fig. 3

Overall survival by TP53 mutation, high complexity, and monosomal karyotype status. a Overall survival of the entire cohort. b Overall survival stratified by TP53 mutation status. c Overall survival stratified by the number of clonal karyotype abnormalities. d Overall survival stratified by monosomal karyotype status. e Stratification of overall survival by TP53 mutation status in patients with a monosomal karyotype. f Stratification of overall survival by TP53 mutation status in patients without a monosomal karyotype